Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

United States Toxoid Vaccines Market Report 2021

  • QYR684283
  • 105 Pages
  • August 2016
  • Pharmaceuticals
Download Sample    Get Discount   
 
Notes:

Sales, means the sales volume of Toxoid Vaccines

Revenue, means the sales value of Toxoid Vaccines

This report studies sales (consumption) of Toxoid Vaccines in USA market, focuses on the top players, with sales, price, revenue and market share for each player, covering

Astellas Pharma Inc

CSL Limited

Emergent BioSolutions, Inc

GlaxoSmithKline

Johnson & Johnson

MedImmune, LLC

Merck & Co

Pfizer

Sanofi Pasteur

Serum Institute

India Pvt. Ltd. (India)

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

Pneumococcal

Influenza

HPV

Hepatitis

Rotavirus

DTP

Polio

MMR

Split by applications, this report focuses on sales, market share and growth rate of Toxoid Vaccines in each application, can be divided into

Pediatric

Adult

Application 3

Table of Contents

United States Toxoid Vaccines Market Report 2021

1 Toxoid Vaccines Overview

1.1 Product Overview and Scope of Toxoid Vaccines

1.2 Classification of Toxoid Vaccines

1.2.1 Pneumococcal

1.2.2 Influenza

1.2.3 HPV

1.2.4 Hepatitis

1.2.5 Rotavirus

1.2.6 DTP

1.2.7 Polio

1.2.8 MMR

1.3 Applications of Toxoid Vaccines

1.3.1 Pediatric

1.3.2 Adult

1.3.3 Application 3

1.4 USA Market Size (Value and Volume) of Toxoid Vaccines (2011-2021)

1.4.1 USA Toxoid Vaccines Sales, Revenue and Price (2011-2021)

1.4.2 USA Toxoid Vaccines Sales and Growth Rate (2011-2021)

1.4.3 USA Toxoid Vaccines Revenue and Growth Rate (2011-2021)

2 USA Toxoid Vaccines Competition by Manufacturers

2.1 USA Toxoid Vaccines Sales and Market Share of Key Manufacturers (2015 and 2016)

2.2 USA Toxoid Vaccines Revenue and Share by Manufactures (2015 and 2016)

3 USA Toxoid Vaccines (Volume and Value) by Type

3.1 USA Toxoid Vaccines Sales and Market Share by Type (2011-2021)

3.2 USA Toxoid Vaccines Revenue and Market Share by Type (2011-2021)

4 USA Toxoid Vaccines (Volume) by Application

5 USA Toxoid Vaccines Manufacturers Analysis

5.1 Astellas Pharma Inc

5.1.1 Company Basic Information, Manufacturing Base and Competitors

5.1.2 Toxoid Vaccines Product Type and Technology

5.1.2.1 Pneumococcal

5.1.2.2 Influenza

5.1.3 Toxoid Vaccines Sales, Revenue, Price of Astellas Pharma Inc (2015 and 2016)

5.2 CSL Limited

5.2.1 Company Basic Information,Manufacturing Base and Competitors

5.2.2 Pharmaceuticals Product Type and Technology

5.2.2.1 Pneumococcal

5.2.2.2 Influenza

5.2.3 Pharmaceuticals Sales, Revenue, Price of CSL Limited (2015 and 2016)

5.3 Emergent BioSolutions, Inc

5.3.1 Company Basic Information,Manufacturing Base and Competitors

5.3.2 Emergent BioSolutions, Inc Product Type and Technology

5.3.2.1 Pneumococcal

5.3.2.2 Influenza

5.3.3 Emergent BioSolutions, Inc Sales, Revenue, Price of Emergent BioSolutions, Inc (2015 and 2016)

5.4 GlaxoSmithKline

5.4.1 Company Basic Information,Manufacturing Base and Competitors

5.4.2 Sanofi Pasteur Product Type and Technology

5.4.2.1 Pneumococcal

5.4.2.2 Influenza

5.4.3 GlaxoSmithKline Sales, Revenue, Price of GlaxoSmithKline (2015 and 2016)

5.5 Johnson & Johnson

5.5.1 Company Basic Information,Manufacturing Base and Competitors

5.5.2 Johnson & Johnson Product Type and Technology

5.5.2.1 Pneumococcal

5.5.2.2 Influenza

5.5.3 Johnson & Johnson Sales, Revenue, Price of Johnson & Johnson (2015 and 2016)

5.6 MedImmune, LLC

5.6.1 Company Basic Information,Manufacturing Base and Competitors

5.6.2 MedImmune, LLC Product Type and Technology

5.6.2.1 Pneumococcal

5.6.2.2 Influenza

5.6.3 MedImmune, LLC Sales, Revenue, Price of MedImmune, LLC (2015 and 2016)

5.7 Merck & Co

5.7.1 Company Basic Information,Manufacturing Base and Competitors

5.7.2 Merck & Co Product Type and Technology

5.7.2.1 Pneumococcal

5.7.2.2 Influenza

5.7.3 Merck & Co Sales, Revenue, Price of Merck & Co (2015 and 2016)

5.8 Pfizer

5.8.1 Company Basic Information,Manufacturing Base and Competitors

5.8.2 Pfizer Product Type and Technology

5.8.2.1 Pneumococcal

5.8.2.2 Influenza

5.8.3 Pfizer Sales, Revenue, Price of Pfizer (2015 and 2016)

5.9 Sanofi Pasteur

5.9.1 Company Basic Information,Manufacturing Base and Competitors

5.9.2 Sanofi Pasteur Product Type and Technology

5.9.2.1 Pneumococcal

5.9.2.2 Influenza

5.9.3 Sanofi Pasteur Sales, Revenue, Price of Sanofi Pasteur (2015 and 2016)

5.10 Serum Institute

5.10.1 Company Basic Information,Manufacturing Base and Competitors

5.10.2 Serum Institute Product Type and Technology

5.10.2.1 Pneumococcal

5.10.2.2 Influenza

5.10.3 Serum Institute Sales, Revenue, Price of Serum Institute (2015 and 2016)

5.11 India Pvt. Ltd. (India)

6 Toxoid Vaccines Technology and Development Trend

6.1 Toxoid Vaccines Technology Analysis

6.2 Toxoid Vaccines Technology Development Trend

7 Research Findings and Conclusion

List of Tables and Figures

Figure Picture of Toxoid Vaccines

Table Classification of Toxoid Vaccines

Figure USA Sales Market Share of Toxoid Vaccines by Type in 2015

Figure Pneumococcal Picture

Figure Influenza Picture

Figure HPV Picture

Figure Hepatitis Picture

Figure Rotavirus Picture

Figure DTP Picture

Figure Polio Picture

Figure MMR Picture

Table Applications of Toxoid Vaccines

Figure USA Sales Market Share of Toxoid Vaccines by Application in 2015

Figure Pediatric Examples

Figure Adult Examples

Table USA Toxoid Vaccines Sales, Revenue and Price (2011-2021)

Figure USA Toxoid Vaccines Sales and Growth Rate (2011-2021)

Figure USA Toxoid Vaccines Revenue and Growth Rate (2011-2021)

Table USA Toxoid Vaccines Sales of Key Manufacturers (2015 and 2016)

Table USA Toxoid Vaccines Sales Share by Manufacturers (2015 and 2016)

Figure 2015 Toxoid Vaccines Sales Share by Manufacturers

Figure 2016 Toxoid Vaccines Sales Share by Manufacturers

Table USA Toxoid Vaccines Revenue by Manufacturers (2015 and 2016)

Table USA Toxoid Vaccines Revenue Share by Manufacturers (2015 and 2016)

Table 2015 USA Toxoid Vaccines Revenue Share by Manufacturers

Table 2016 USA Toxoid Vaccines Revenue Share by Manufacturers

Table USA Toxoid Vaccines Sales and Market Share by Type (2011-2021)

Table USA Toxoid Vaccines Sales Share by Type (2011-2021)

Figure Sales Market Share of Toxoid Vaccines by Type (2011-2021)

Figure USA Toxoid Vaccines Sales Growth Rate by Type (2011-2021)

Table USA Toxoid Vaccines Revenue and Market Share by Type (2011-2021)

Table USA Toxoid Vaccines Revenue Share by Type (2011-2021)

Figure Revenue Market Share of Toxoid Vaccines by Type (2011-2021)

Figure USA Toxoid Vaccines Revenue Growth Rate by Type (2011-2021)

Table USA Toxoid Vaccines Sales and Market Share by Application (2011-2021)

Table USA Toxoid Vaccines Sales Share by Application (2011-2021)

Figure Sales Market Share of Toxoid Vaccines by Application (2011-2021)

Figure USA Toxoid Vaccines Sales Growth Rate by Application (2011-2021)

Table Astellas Pharma Inc Basic Information List

Table Toxoid Vaccines Sales, Revenue, Price of Astellas Pharma Inc (2015 and 2016)

Table CSL Limited Basic Information List

Table Toxoid Vaccines Sales, Revenue, Price of CSL Limited (2015 and 2016)

Table Emergent BioSolutions, Inc Basic Information List

Table Toxoid Vaccines Sales, Revenue, Price of Emergent BioSolutions, Inc (2015 and 2016)

Table GlaxoSmithKline Basic Information List

Table Toxoid Vaccines Sales, Revenue, Price of GlaxoSmithKline (2015 and 2016)

Table Johnson & Johnson Basic Information List

Table Toxoid Vaccines Sales, Revenue, Price of Johnson & Johnson (2015 and 2016)

Table MedImmune, LLC Basic Information List

Table Toxoid Vaccines Sales, Revenue, Price of MedImmune, LLC (2015 and 2016)

Table Merck & Co Basic Information List

Table Toxoid Vaccines Sales, Revenue, Price of Merck & Co (2015 and 2016)

Table Pfizer Basic Information List

Table Toxoid Vaccines Sales, Revenue, Price of Pfizer (2015 and 2016)

Table Sanofi Pasteur Basic Information List

Table Toxoid Vaccines Sales, Revenue, Price of Sanofi Pasteur (2015 and 2016)

Table Serum Institute Basic Information List

Table Toxoid Vaccines Sales, Revenue, Price of Serum Institute (2015 and 2016)

Table India Pvt. Ltd. (India) Basic Information List

Table Toxoid Vaccines Sales, Revenue, Price of India Pvt. Ltd. (India) (2015 and 2016)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390